These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12515340)

  • 1. Laboratory security and emergency response guidance for laboratories working with select agents. Centers for Disease Control and Prevention.
    Richmond JY; Nesby-O'Dell SL
    MMWR Recomm Rep; 2002 Dec; 51(RR-19):1-6. PubMed ID: 12515340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel.
    Miller JM; Astles R; Baszler T; Chapin K; Carey R; Garcia L; Gray L; Larone D; Pentella M; Pollock A; Shapiro DS; Weirich E; Wiedbrauk D; ;
    MMWR Suppl; 2012 Jan; 61(1):1-102. PubMed ID: 22217667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological research and security institutes].
    Darsie G; Falczuk AJ; Bergmann IE
    Rev Sci Tech; 2006 Apr; 25(1):321-7. PubMed ID: 16796057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.
    Smith J; Gangadharan D; Weyant R
    Health Secur; 2015; 13(5):307-16. PubMed ID: 26347984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of biosurety systems in a Department of Defense medical research laboratory.
    Carr K; Henchal EA; Wilhelmsen C; Carr B
    Biosecur Bioterror; 2004; 2(1):7-16. PubMed ID: 15068675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSL-3 laboratory practices in the United States: comparison of select agent and non-select agent facilities.
    Richards SL; Pompei VC; Anderson A
    Biosecur Bioterror; 2014; 12(1):1-7. PubMed ID: 24552359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodefense research: can secrecy and safety coexist?
    Kahn LH
    Biosecur Bioterror; 2004; 2(2):81-5. PubMed ID: 15225401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
    Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
    Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biosafety of microbiological laboratories in Korea].
    Lee JY; Eun SJ; Park KD; Kim JK; Im JS; Hwang YS; Kim YI
    J Prev Med Public Health; 2005 Nov; 38(4):449-56. PubMed ID: 16358832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical laboratories, the select agent program, and biological surety (biosurety).
    Pastel RH; Demmin G; Severson G; Torres-Cruz R; Trevino J; Kelly J; Arrison J; Christman J
    Clin Lab Med; 2006 Jun; 26(2):299-312, vii. PubMed ID: 16815454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.
    Munson E; Bowles EJ; Dern R; Beck E; Podzorski RP; Bateman AC; Block TK; Kropp JL; Radke T; Siebers K; Simmons B; Smith MA; Spray-Larson F; Warshauer DM
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized emergency management system and response to a smallpox emergency.
    Kim-Farley RJ; Celentano JT; Gunter C; Jones JW; Stone RA; Aller RD; Mascola L; Grigsby SF; Fielding JE
    Prehosp Disaster Med; 2003; 18(4):313-20. PubMed ID: 15310043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15.
    Bjork A; Sosin DM
    Health Secur; 2017; 15(6):587-598. PubMed ID: 29193983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioterrorism and biological threats dominate federal health security research; other priorities get scant attention.
    Shelton SR; Connor K; Uscher-Pines L; Pillemer FM; Mullikin JM; Kellermann AL
    Health Aff (Millwood); 2012 Dec; 31(12):2755-63. PubMed ID: 23213160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Code of Conduct on Biosecurity for Biological Resource Centres: procedural implementation.
    Rohde C; Smith D; Martin D; Fritze D; Stalpers J
    Int J Syst Evol Microbiol; 2013 Jul; 63(Pt 7):2374-2382. PubMed ID: 23667143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for facilities transferring or receiving select agents. Final rule.
    Center for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2001 Aug; 66(170):45944-5. PubMed ID: 11757572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.